SCHEMBL416541

SCHEMBL416541

O=C(c1nc2ccccc2[nH]1)[C@@H]1CCCN1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.53
FAAH O00519 1/20 0.47
AURKA O14965 1/20 0.45
JAK2 O60674 1/20 0.45
ABL1 P00519 1/20 0.45
NTRK1 P04629 1/20 0.45
LCK P06239 1/20 0.45
FYN P06241 1/20 0.45
CSF1R P07333 1/20 0.45
RET P07949 1/20 0.45
IGF1R P08069 1/20 0.45
MET P08581 1/20 0.45
PDGFRB P09619 1/20 0.45
PIM1 P11309 1/20 0.45
FGFR1 P11362 1/20 0.45
PRKACA P17612 1/20 0.45
KDR P35968 1/20 0.45
MAP2K2 P36507 1/20 0.45
CDK8 P49336 1/20 0.45
GSK3A P49840 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27573147 0.78 SMN1; SMN2 (0.58) FAAHAURKAJAK2ABL1NTRK1
SCHEMBL456348 0.77 SMYD3 (0.47) FAAHAURKAJAK2ABL1NTRK1
SCHEMBL456347 0.77 FAAH (0.47) FAAHAURKAJAK2ABL1NTRK1
SCHEMBL27553073 0.77 ELANE (0.47) ELANEFAAHGSK3AGSK3BSMN1; SMN2
SCHEMBL7469771 0.77 SMN1; SMN2 (0.49) FAAHAURKAJAK2ABL1NTRK1
Iodide SCHEMBL7947067 0.76 SMN1; SMN2 (0.48) FAAHAURKAJAK2ABL1NTRK1
SCHEMBL1444156 0.74 MAOB (0.52) ELANECNR2SMN1; SMN2NPC1RAB9A
SCHEMBL28078689 0.72 AURKA (0.51) FAAHAURKAJAK2ABL1NTRK1
SCHEMBL250171 0.71 CCND3 (0.70) FAAHAURKAJAK2ABL1NTRK1
SCHEMBL741003 0.71 POLB (0.54) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675474-B9 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS TIERGESUNDHEIT AG (CH) 2018-12-05 EP claimed
US-20170136080-A1 NOVEL METHOD FOR THE TOPICAL APPLICATION OF VETERINARY AGENTS Ceva Santé Animale (FR) 2017-05-18 US claimed
EP-3160506-A1 NOVEL METHOD FOR THE TOPICAL APPLICATION OF VETERINARY AGENTS Ceva Sante Animale (FR) 2017-05-03 EP claimed
EP-1675474-B2 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS TIERGESUNDHEIT AG (CH) 2016-12-07 EP claimed
WO-2016001216-A1 NOVEL METHOD FOR THE TOPICAL APPLICATION OF VETERINARY AGENTS CEVA SANTE ANIMALE (FR) 2016-01-07 WO claimed
US-20140094418-A1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS AG (CH) 2014-04-03 US claimed
JP-4754139-B2 2011-08-24 JP claimed
US-20090062362-A1 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System ELANCO ANIMAL HEALTH IRELAND LIMITED (IE) 2009-03-05 US claimed
EP-1675474-B1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS AG (CH) 2008-10-22 EP claimed
JP-2007500004-A 2007-01-11 JP claimed
US-20060222684-A1 Palatable ductile chewable veterinary composition ELANCO TIERGESUNDHEIT AG (CH) 2006-10-05 US claimed
EP-1675474-A1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION Novartis AG (CH) 2006-07-05 EP claimed
WO-2005013714-A1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS AG (CH) 2005-02-17 WO claimed
EP-1214052-B1 VETERINARY FORMULATION FOR ADMINISTRATION OF A WATER-INSOLUBLE DRUG TO A TARGET ANIMAL THROUGH A WATER DISTRIBUTION SYSTEM JANSSEN PHARMACEUTICA NV (BE) 2004-08-11 EP claimed
EP-1214052-A1 VETERINARY FORMULATION FOR ADMINISTRATION OF A WATER-INSOLUBLE DRUG TO A TARGET ANIMAL THROUGH A WATER DISTRIBUTION SYSTEM JANSSEN PHARMACEUTICA N.V. (BE) 2002-06-19 EP claimed
WO-2001017504-A1 VETERINARY FORMULATION FOR ADMINISTRATION OF A WATER-INSOLUBLE DRUG TO A TARGET ANIMAL THROUGH A WATER DISTRIBUTION SYSTEM JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-15 WO claimed
EP-0497240-B1 Preparation for controlled release of drugs for ruminants HOECHST AG (DE) 1998-04-08 EP claimed
EP-0497240-A1 Preparation for controlled release of drugs for ruminants HOECHST AKTIENGESELLSCHAFT (DE) 1992-08-05 EP claimed
EP-0496316-A1 Pour-on formulation for application of anthelminthics HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-29 EP claimed
US-11911503-B2 Manufacturing of semi-plastic pharmaceutical dosage units INTERVET INC. (US) 2024-02-27 US disclosed
US-20240043446-A1 ANTHELMINTIC COMPOUNDS COMPRISING A THIENOPYRIDINE STRUCTURE INTERVET INC. (US) 2024-02-08 US disclosed
US-20240043385-A1 ANTHELMINTIC COMPOUNDS COMPRISING A PYRIDINE STRUCTURE INTERVET INC. (US) 2024-02-08 US disclosed
EP-4284509-A1 ANTIPARASITIC COMPOUNDS Intervet International B.V. (NL) 2023-12-06 EP disclosed
EP-4153133-B1 INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTERVET INT BV (NL) 2023-11-08 EP disclosed
US-20230310386-A1 INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTERVET INC. (US) 2023-10-05 US disclosed
US-20230277448-A1 CHEWABLE FORMULATIONS ELANCO TIERGESUNDHEIT AG (CH) 2023-09-07 US disclosed
US-20230263859-A1 SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE COCOON BIOTECH, INC. 2023-08-24 US disclosed
EP-4208155-A1 CHEWABLE FORMULATIONS Elanco Tiergesundheit AG (CH) 2023-07-12 EP disclosed
US-20230148316-A1 ANTHELMINTIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE INTERVET INC. (US) 2023-05-11 US disclosed
US-11633455-B2 Silk-based product formulations and methods of use COCOON BIOTECH INC. (US) 2023-04-25 US disclosed
CN-111989328-B Heterocyclic derivatives as pest control agents 拜耳公司 2023-04-18 CN disclosed
US-20230110397-A1 ANTHELMINTIC COMPOUNDS COMPRISING AZAINDOLES STRUCTURE INTERVET INC. (US) 2023-04-13 US disclosed
CN-112368280-B Heterocyclic derivatives as pest control agents 拜耳公司 2023-01-20 CN disclosed
CN-114929215-A Palatable soft chews 礼蓝美国公司 2022-08-19 CN disclosed
CN-114786484-A Composition for lice control 英特维特国际股份有限公司 2022-07-22 CN disclosed
US-20220218717-A1 PROCESS FOR MANUFACTURING SOFT CHEWABLE FREE FLOWING GRANULES AND COMPANION ANIMAL PRODUCTS THEREOF CUCKOS PHARMACEUTICAL PRIVATE LIMITED (IN) 2022-07-14 US disclosed
EP-4025220-A1 PALATABLE GRANULAR VETERINARY COMPOSITIONS Elanco US Inc. (US) 2022-07-13 EP disclosed
EP-4025209-A1 PALATABLE SOFT-CHEW Elanco US Inc. (US) 2022-07-13 EP disclosed
CN-114727622-A Palatable granular veterinary compositions 礼蓝美国公司 2022-07-08 CN disclosed
US-11337917-B2 Soft chewable pharmaceutical products INTERVET INC. (US) 2022-05-24 US disclosed
US-20220142984-A1 Soft Chewable Pharmaceutical Products INTERVET INC. (US) 2022-05-12 US disclosed
CN-110382485-B Heterocyclene derivatives as pest control agents 拜耳公司 2022-05-10 CN disclosed
CN-105025885-B Tablet with improved acceptance and good storage stability 拜耳动物保健有限责任公司 2022-04-08 CN disclosed
US-11285101-B2 Soft chewable pharmaceutical products INTERVET INC. (US) 2022-03-29 US disclosed
CN-113784702-A Injectable pharmaceutical composition and use thereof 英特维特国际股份有限公司 2021-12-10 CN disclosed
US-20210236420-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units INTERVET INC. (US) 2021-08-05 US disclosed
US-20210228684-A1 SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE COCOON BIOTECH INC. 2021-07-29 US disclosed
EP-3393455-B1 INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE INTERVET INT BV (NL) 2021-07-21 EP disclosed
US-20210177808-A1 INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION INTERVET INC. (US) 2021-06-17 US disclosed
CN-112912377-A Heterocyclic derivatives as pest control agents 拜耳公司 2021-06-04 CN disclosed
US-20210138071-A1 SILK-BASED PRODUCTS AND METHODS OF USE COCOON BIOTECH INC. 2021-05-13 US disclosed
US-20210107874-A1 PHARMACEUTICAL FORMULATION OF CROTONYLAMINOPYRIDINE SALT INTERVET INC. (US) 2021-04-15 US disclosed
US-10973759-B2 Manufacturing of semi-plastic pharmaceutical dosage units INTERVET INC. (US) 2021-04-13 US disclosed
US-20210069104-A1 PALATABLE SOFT-CHEW BAYER HEALTHCARE LLC 2021-03-11 US disclosed
US-20210068425-A1 PALATABLE GRANULAR VETERINARY COMPOSITIONS BAYER HEALTHCARE LLC 2021-03-11 US disclosed
WO-2021046305-A1 PALATABLE GRANULAR VETERINARY COMPOSITIONS BAYER HEALTHCARE LLC (US) 2021-03-11 WO disclosed
WO-2021046296-A1 PALATABLE SOFT-CHEW BAYER HEALTHCARE LLC (US) 2021-03-11 WO disclosed
CN-112368280-A Heterocyclic derivatives as pest control agents 拜耳公司 2021-02-12 CN disclosed
WO-2020234898-A1 PROCESS FOR MANUFACTURING SOFT CHEWABLE FREE FLOWING GRANULES AND COMPANION ANIMAL PRODUCTS THEREOF CUCKOS PHARMACEUTICAL PRIVATE LIMITED (IO) 2020-11-26 WO disclosed
CN-111989328-A Heterocyclic derivatives as pest control agents 拜耳公司 2020-11-24 CN disclosed
US-10820593-B2 Methods of preparing alkaloid containing compositions and uses thereof SYNGENTA PARTICIPATIONS AG (CH) 2020-11-03 US disclosed
US-20200199139-A1 Alkaloid-Containing Compositions and Uses Thereof BIOTELLIGA HOLDINGS LIMITED (NZ) 2020-06-25 US disclosed
EP-2627314-B1 NON-STARCH BASED SOFT CHEWABLES BAYER IP GMBH (DE) 2020-05-06 EP disclosed
EP-3600300-A1 PHARMACEUTICAL FORMULATION OF CROTONYLAMINOPYRIDINE SALT Intervet International B.V. (NL) 2020-02-05 EP disclosed
US-20190336442-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units INTERVET INC. (US) 2019-11-07 US disclosed
EP-2831042-B1 HETEROARYL COMPOUNDS WITH A-CYCLIC BRIDGING UNIT INTERVET INT BV (NL) 2019-07-31 EP disclosed
US-20190201332-A1 Soft Chewable Pharmaceutical Products INTERVET INC. (US) 2019-07-04 US disclosed
US-20190117564-A1 Soft Chewable Pharmaceutical Products INTERVET INC. (US) 2019-04-25 US disclosed
US-20190117565-A1 Soft Chewable Pharmaceutical Product INTERVET INC. (US) 2019-04-25 US disclosed
EP-1675474-B9 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS TIERGESUNDHEIT AG (CH) 2018-12-05 EP disclosed
EP-2833866-B1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS INTERVET INT BV (NL) 2018-11-21 EP disclosed
EP-3393455-A1 INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE Intervet International B.V. (NL) 2018-10-31 EP disclosed
WO-2018178345-A1 PHARMACEUTICAL FORMULATION OF CROTONYLAMINOPYRIDINE SALT INTERVET INTERNATIONAL B.V. (NL) 2018-10-04 WO disclosed
US-20180280367-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS INTERVET INC. (US) 2018-10-04 US disclosed
US-20180263905-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units INTERVET INC. (US) 2018-09-20 US disclosed
US-10010538-B2 Use of anthelmintic agents against Dirofilaria immitis INTERVET INC. (US) 2018-07-03 US disclosed
CN-105294549-B N heteroaryl compounds 英特维特国际股份有限公司 2017-12-26 CN disclosed
US-20170332641-A1 METHODS OF PREPARING ALKALOID CONTAINING COMPOSITIONS AND USES THEREOF SYNGENTA PARTICIPATIONS AG (CH) 2017-11-23 US disclosed
US-20170290766-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS INTERVET, INC. (US) 2017-10-12 US disclosed
US-20170266165-A1 Soft Chewable Pharmaceutical Products INTERVET INC. (US) 2017-09-21 US disclosed
US-9744127-B2 Non-starch based soft chewables BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-08-29 US disclosed
CN-106998690-A Process for preparing alkaloid-containing compositions and their use 先正达参股股份有限公司 2017-08-01 CN disclosed
US-20170202816-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS INTERVET INC. (US) 2017-07-20 US disclosed
US-20170196854-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS INTERVET INC. (US) 2017-07-13 US disclosed
WO-2017108954-A1 INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE INTERVET INTERNATIONAL B.V. (NL) 2017-06-29 WO disclosed
US-20170172918-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS INTERVET, INC. (US) 2017-06-22 US disclosed
US-20170172986-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS INTERVET, INC. (US) 2017-06-22 US disclosed
US-20170157040-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units INTERVET INC. (US) 2017-06-08 US disclosed
US-20170136080-A1 NOVEL METHOD FOR THE TOPICAL APPLICATION OF VETERINARY AGENTS Ceva Santé Animale (FR) 2017-05-18 US disclosed
EP-3160506-A1 NOVEL METHOD FOR THE TOPICAL APPLICATION OF VETERINARY AGENTS Ceva Sante Animale (FR) 2017-05-03 EP disclosed
US-20170105972-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS INTERVET, INC. (US) 2017-04-20 US disclosed
EP-2621923-B1 N-HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR THE TREATMENT OF PARASITIC DISEASES INTERVET INT BV (NL) 2017-03-29 EP disclosed
US-9598412-B2 Spiroindoline compounds for use as anthelminthics INTERVET INC. (US) 2017-03-21 US disclosed
EP-2621903-B1 N-HETEROARYL COMPOUNDS INTERVET INT BV (NL) 2017-03-01 EP disclosed
US-9532946-B2 Manufacturing of semi-plastic pharmaceutical dosage units INTERVET INC. (US) 2017-01-03 US disclosed
EP-1675474-B2 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS TIERGESUNDHEIT AG (CH) 2016-12-07 EP disclosed
EP-2739626-B1 NOVEL SPIROINDOLINE COMPOUNDS INTERVET INT BV (NL) 2016-05-04 EP disclosed
US-9321724-B2 Heteroaryl compounds with A-cyclic bridging unit INTERVET INC. (US) 2016-04-26 US disclosed
US-9260441-B2 Heteroaryl compounds with cyclic bridging unit INTERVET INC. (US) 2016-02-16 US disclosed
CN-105294549-A N-HETEROARYL COMPOUNDS INTERVET INT BV 2016-02-03 CN disclosed
WO-2016001216-A1 NOVEL METHOD FOR THE TOPICAL APPLICATION OF VETERINARY AGENTS CEVA SANTE ANIMALE (FR) 2016-01-07 WO disclosed
CN-103189356-B N-heteroaryl compounds INTERVET INTERNATIONAL B.V. (NL) 2015-11-25 CN disclosed
CN-105025885-A Tablet with improved acceptance and good storage stability BAYER ANIMAL HEALTH GMBH 2015-11-04 CN disclosed
US-9096599-B2 Spiroindoline compounds INTERVET INC. (US) 2015-08-04 US disclosed
US-9096524-B2 Anthelmintic agents and their use INTERVET INTERNATIONAL B.V. (NL) 2015-08-04 US disclosed
US-9040571-B2 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system ELANCO ANIMAL HEALTH IRELAND LIMITED (IE) 2015-05-26 US disclosed
US-20150080365-A1 HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT INTERVET INC. 2015-03-19 US disclosed
US-20150057279-A1 HETEROARYL COMPOUNDS WITH A-CYCLIC BRIDGING UNIT INTERVET INC. 2015-02-26 US disclosed
US-20150057302-A1 SPIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHICS INTERVET INC. 2015-02-26 US disclosed
US-20150057321-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS INTERVET INC. 2015-02-26 US disclosed
EP-2830615-A1 HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR USE IN THE TREATMENT HELMINTH INFECTION Intervet International B.V. (NL) 2015-02-04 EP disclosed
EP-2831042-A1 HETEROARYL COMPOUNDS WITH A-CYCLIC BRIDGING UNIT Intervet International B.V. (NL) 2015-02-04 EP disclosed
CN-104203214-A soft chewable pharmaceutical product INTERVET INT BV 2014-12-10 CN disclosed
US-8883791-B2 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases INTERVET INC. (US) 2014-11-11 US disclosed
US-8877934-B2 N-heteroaryl compounds INTERVET INC. (US) 2014-11-04 US disclosed
EP-2408742-B1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INT BV (NL) 2014-09-03 EP disclosed
EP-2234973-B1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INT BV (NL) 2014-07-02 EP disclosed
US-20140163056-A1 NOVEL SPIROINDOLINE COMPOUNDS INTERVET INC. 2014-06-12 US disclosed
US-20140141055-A1 MANUFACTURING OF SEMI-PLASTIC PHARMACEUTICAL DOSAGE UNITS INTERVET INC. 2014-05-22 US disclosed
EP-2531506-B1 Spiroindoline compounds for use as anthelminthics INTERVET INT BV (NL) 2014-05-14 EP disclosed
US-20140094418-A1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS AG (CH) 2014-04-03 US disclosed
US-8569495-B2 Anthelmintic agents and their use INTERVET INTERNATIONAL B.V. (NL) 2013-10-29 US disclosed
WO-2013144179-A1 HETEROARYL COMPOUNDS WITH A-CYCLIC BRIDGING UNIT INTERVET INTERNATIONAL B.V. (NL) 2013-10-03 WO disclosed
WO-2013144180-A1 HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR USE IN THE TREATMENT HELMINTH INFECTION INTERVET INTERNATIONAL B.V. (NL) 2013-10-03 WO disclosed
US-8541019-B2 Palatable ductile chewable veterinary composition NOVARTIS AG (CH) 2013-09-24 US disclosed
EP-2627314-A1 NON-STARCH BASED SOFT CHEWABLES Bayer Intellectual Property GmbH (DE) 2013-08-21 EP disclosed
US-8507474-B2 Anthelmintic agents and their use INTERVET INTERNATIONAL B.V. (NL) 2013-08-13 US disclosed
US-20130203768-A1 N-HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR THE TREATMENT OF PARASITIC DISEASES INTERVET INC. 2013-08-08 US disclosed
EP-2621903-A1 N-HETEROARYL COMPOUNDS Intervet International B.V. (NL) 2013-08-07 EP disclosed
EP-2621923-A1 N-HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR THE TREATMENT OF PARASITIC DISEASES Intervet International B.V. (NL) 2013-08-07 EP disclosed
US-20130196993-A1 N-HETEROARYL COMPOUNDS INTERVET INC. 2013-08-01 US disclosed
US-20130197006-A1 Non-Starch Based Soft Chewables BAYER ANIMAL HEALTH GMBH (DE) 2013-08-01 US disclosed
CN-103200930-A Non-starch based soft chewables BAYER IP GMBH 2013-07-10 CN disclosed
CN-103189356-A N-heteroaryl compounds INTERVET INT BV 2013-07-03 CN disclosed
EP-2585062-A1 INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE Intervet International B.V. (NL) 2013-05-01 EP disclosed
US-20130090296-A1 INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE CHO HYUN SUN (BR) 2013-04-11 US disclosed
EP-2443091-B1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INT BV (NL) 2013-04-03 EP disclosed
EP-2531506-A1 S PIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHI CS Intervet International B.V. (NL) 2012-12-12 EP disclosed
US-20120295931-A1 SPIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHICS INTERVET INC. 2012-11-22 US disclosed
EP-2468096-A1 Anthelmintic combinations Intervet International BV (NL) 2012-06-27 EP disclosed
EP-2443091-A1 ANTHELMINTIC AGENTS AND THEIR USE Intervet International B.V. (NL) 2012-04-25 EP disclosed
US-20120094981-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2012-04-19 US disclosed
WO-2012049156-A1 NON-STARCH BASED SOFT CHEWABLES BAYER ANIMAL HEALTH GMBH (DE) 2012-04-19 WO disclosed
WO-2012046207-A1 ANTI-PARASITIC SUBSTITUTED RING FUSED AZINE COMPOUNDS PARACO TECHNOLOGY LIMITED (NZ) 2012-04-12 WO disclosed
WO-2012041873-A1 N-HETEROARYL COMPOUNDS INTERVET INTERNATIONAL B.V. (NL) 2012-04-05 WO disclosed
WO-2012041872-A1 N-HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR THE TREATMENT OF PARASITIC DISEASES INTERVET INTERNATIONAL B.V. (NL) 2012-04-05 WO disclosed
US-20120046296-A1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION ELANCO TIERGESUNDHEIT AG (CH) 2012-02-23 US disclosed
EP-2408742-A1 ANTHELMINTIC AGENTS AND THEIR USE Intervet International B.V. (NL) 2012-01-25 EP disclosed
WO-2011161209-A1 INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE INTERVET INTERNATIONAL B.V. (NL) 2011-12-29 WO disclosed
US-20110319393-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2011-12-29 US disclosed
WO-2011095581-A1 S PIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHI CS INTERVET INTERNATIONAL B.V. (NL) 2011-08-11 WO disclosed
US-20110021506-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2011-01-27 US disclosed
WO-2010146083-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2010-12-23 WO disclosed
WO-2010115688-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2010-10-14 WO disclosed
EP-2234973-A1 ANTHELMINTIC AGENTS AND THEIR USE Intervet International B.V. (NL) 2010-10-06 EP disclosed
WO-2009077527-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2009-06-25 WO disclosed
US-20090062362-A1 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System ELANCO ANIMAL HEALTH IRELAND LIMITED (IE) 2009-03-05 US disclosed
WO-2008152081-A2 ANTHELMINTIC BENZO[D]ISOXAZOLYL BENZAMIDE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2008-12-18 WO disclosed
US-20080287511-A1 Anthelmintic Imidazol-Thiazole Derivates AVISTAR COMMUNICATIONS CORPORATION 2008-11-20 US disclosed
EP-1675474-B1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS AG (CH) 2008-10-22 EP disclosed
US-20080076703-A1 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium CELL GENESYS, INC. (US) 2008-03-27 US disclosed
US-20060222684-A1 Palatable ductile chewable veterinary composition ELANCO TIERGESUNDHEIT AG (CH) 2006-10-05 US disclosed
EP-1675474-A1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION Novartis AG (CH) 2006-07-05 EP disclosed
US-20050059613-A1 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium CELL GENESYS, INC. 2005-03-17 US disclosed
WO-2005013714-A1 PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION NOVARTIS AG (CH) 2005-02-17 WO disclosed
WO-2005007101-A2 COMPOSITIONS AND METHODS FOR THE ENHANCED UPTAKE OF THERAPEUTIC AGENTS THROUGH THE BLADDER EPITHELIUM CELL GENESYS, INC. (US) 2005-01-27 WO disclosed
EP-1214052-B1 VETERINARY FORMULATION FOR ADMINISTRATION OF A WATER-INSOLUBLE DRUG TO A TARGET ANIMAL THROUGH A WATER DISTRIBUTION SYSTEM JANSSEN PHARMACEUTICA NV (BE) 2004-08-11 EP disclosed
EP-1237408-B1 POUR-ON FORMULATIONS LILLY CO ELI (US) 2004-02-18 EP disclosed
WO-2003051281-A2 COMPOSITION AND METHOD TO TREAT VIRAL BACTERIAL AND PARASITIC INFECTIONS AND INFESTATIONS GANADO RESEARCH, L.L.C. (US) 2003-06-26 WO disclosed
EP-1214052-A1 VETERINARY FORMULATION FOR ADMINISTRATION OF A WATER-INSOLUBLE DRUG TO A TARGET ANIMAL THROUGH A WATER DISTRIBUTION SYSTEM JANSSEN PHARMACEUTICA N.V. (BE) 2002-06-19 EP disclosed
WO-2001017504-A1 VETERINARY FORMULATION FOR ADMINISTRATION OF A WATER-INSOLUBLE DRUG TO A TARGET ANIMAL THROUGH A WATER DISTRIBUTION SYSTEM JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-15 WO disclosed
EP-0497240-B1 Preparation for controlled release of drugs for ruminants HOECHST AG (DE) 1998-04-08 EP disclosed
EP-0497240-A1 Preparation for controlled release of drugs for ruminants HOECHST AKTIENGESELLSCHAFT (DE) 1992-08-05 EP disclosed
EP-0496316-A1 Pour-on formulation for application of anthelminthics HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-29 EP disclosed
EP-0496316-A1 Pour-on formulation for application of anthelminthics HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-29 EP disclosed
EP-0496316-A1 Pour-on formulation for application of anthelminthics HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210177808-A1 INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION INA, MMP1, EPX ELANE 437/4885FAAH 2695/4885AURKA 4519/4885
US-20110021506-A1 ANTHELMINTIC AGENTS AND THEIR USE ACHE, ABCB11, MPO ELANE 113/4885FAAH 228/4885AURKA 1046/4885
US-20110319393-A1 ANTHELMINTIC AGENTS AND THEIR USE ACHE, ABCB11, MPO ELANE 113/4885FAAH 228/4885AURKA 1046/4885
US-20180263905-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units PUF60, RPS11, RPS20 ELANE 4476/4885FAAH 4017/4885AURKA 4249/4885
US-20170157040-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units PUF60, RPS11, RPS20 ELANE 4476/4885FAAH 4017/4885AURKA 4249/4885
US-20050059613-A1 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium MUC1, SLC17A5, CD44 ELANE 218/4885FAAH 3611/4885AURKA 4871/4885
US-20140141055-A1 MANUFACTURING OF SEMI-PLASTIC PHARMACEUTICAL DOSAGE UNITS PUF60, RPS11, RPS20 ELANE 4476/4885FAAH 4017/4885AURKA 4249/4885
US-20150057321-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20060222684-A1 Palatable ductile chewable veterinary composition PIGO, TAS2R41, TAS2R30 ELANE 59/4885FAAH 2217/4885AURKA 4264/4885
US-20220142984-A1 Soft Chewable Pharmaceutical Products PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-10973759-B2 Manufacturing of semi-plastic pharmaceutical dosage units PUF60, RPS11, RPS20 ELANE 4476/4885FAAH 4017/4885AURKA 4249/4885
US-20210236420-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units PUF60, RPS11, RPS20 ELANE 4476/4885FAAH 4017/4885AURKA 4249/4885
US-20080076703-A1 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium MUC1, SLC17A5, CD44 ELANE 218/4885FAAH 3611/4885AURKA 4871/4885
US-20170332641-A1 METHODS OF PREPARING ALKALOID CONTAINING COMPOSITIONS AND USES THEREOF INMT, LSS, ACHE ELANE 3094/4885FAAH 1900/4885AURKA 3146/4885
US-11911503-B2 Manufacturing of semi-plastic pharmaceutical dosage units PUF60, RPS11, RPS20 ELANE 4476/4885FAAH 4017/4885AURKA 4249/4885
US-20150080365-A1 HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT PIGS, MTCL3, GJB2 ELANE 842/4885FAAH 294/4885AURKA 1894/4885
US-11285101-B2 Soft chewable pharmaceutical products PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20240043385-A1 ANTHELMINTIC COMPOUNDS COMPRISING A PYRIDINE STRUCTURE HRH4, PNPO, NME4 ELANE 416/4885FAAH 315/4885AURKA 2252/4885
US-20150057279-A1 HETEROARYL COMPOUNDS WITH A-CYCLIC BRIDGING UNIT AADAC, PIGS, MTCL3 ELANE 1585/4885FAAH 270/4885AURKA 506/4885
US-20230277448-A1 CHEWABLE FORMULATIONS SI, TAS2R39, TAS2R31 ELANE 3089/4885FAAH 1288/4885AURKA 1989/4885
US-20150057302-A1 SPIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHICS PKD2, PKD1, PIR ELANE 1955/4885FAAH 1080/4885AURKA 2533/4885
US-20130196993-A1 N-HETEROARYL COMPOUNDS HNMT, SQLE, PIGO ELANE 245/4885FAAH 192/4885AURKA 2761/4885
US-20170290766-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20170196854-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS MPO, DHODH, DHX35 ELANE 8/4885FAAH 314/4885AURKA 2641/4885
US-20180280367-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS MPO, DHODH, DHX35 ELANE 8/4885FAAH 314/4885AURKA 2641/4885
US-20210069104-A1 PALATABLE SOFT-CHEW TAS2R40, TAS2R45, TAS2R42 ELANE 261/4885FAAH 95/4885AURKA 4639/4885
US-20190117564-A1 Soft Chewable Pharmaceutical Products PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20170266165-A1 Soft Chewable Pharmaceutical Products PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-10010538-B2 Use of anthelmintic agents against Dirofilaria immitis MPO, DHODH, DHX35 ELANE 8/4885FAAH 314/4885AURKA 2641/4885
US-10820593-B2 Methods of preparing alkaloid containing compositions and uses thereof LSS, LARP7, ACHE ELANE 3638/4885FAAH 1910/4885AURKA 1934/4885
US-20190117565-A1 Soft Chewable Pharmaceutical Product PAM, TAS2R46, TAS2R16 ELANE 3541/4885FAAH 1773/4885AURKA 2803/4885
US-20120295931-A1 SPIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHICS PKD2, PKD1, PIR ELANE 1955/4885FAAH 1080/4885AURKA 2533/4885
US-20240043446-A1 ANTHELMINTIC COMPOUNDS COMPRISING A THIENOPYRIDINE STRUCTURE DHODH, NISCH, DDT ELANE 570/4885FAAH 272/4885AURKA 2450/4885
US-20130203768-A1 N-HETEROARYL COMPOUNDS WITH CYCLIC BRIDGING UNIT FOR THE TREATMENT OF PARASITIC DISEASES PIGO, HNMT, PIGS ELANE 609/4885FAAH 331/4885AURKA 2331/4885
US-20080287511-A1 Anthelmintic Imidazol-Thiazole Derivates NOD1, IL33, IL5 ELANE 39/4885FAAH 492/4885AURKA 630/4885
US-20230148316-A1 ANTHELMINTIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE DHX35, DDX5, DHODH ELANE 109/4885FAAH 270/4885AURKA 2325/4885
US-20210107874-A1 PHARMACEUTICAL FORMULATION OF CROTONYLAMINOPYRIDINE SALT SUCNR1, SLC5A2, CS ELANE 4136/4885FAAH 4642/4885AURKA 4236/4885
US-20230310386-A1 INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF CYP3A7, PDE8A, CYP4X1 ELANE 2016/4885FAAH 4688/4885AURKA 3189/4885
US-20210068425-A1 PALATABLE GRANULAR VETERINARY COMPOSITIONS PIGS, VMA21, PGA5 ELANE 1352/4885FAAH 1050/4885AURKA 4479/4885
US-20170105972-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20230110397-A1 ANTHELMINTIC COMPOUNDS COMPRISING AZAINDOLES STRUCTURE AADAC, HNMT, NISCH ELANE 97/4885FAAH 254/4885AURKA 1663/4885
US-11337917-B2 Soft chewable pharmaceutical products PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20170202816-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS MPO, DHODH, DHX35 ELANE 8/4885FAAH 314/4885AURKA 2641/4885
US-20140163056-A1 NOVEL SPIROINDOLINE COMPOUNDS PKD2, PKD1, REN ELANE 2327/4885FAAH 1112/4885AURKA 2964/4885
US-20200199139-A1 Alkaloid-Containing Compositions and Uses Thereof ACHE, TAC3, LARP7 ELANE 3446/4885FAAH 2180/4885AURKA 1495/4885
US-20170172918-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20190201332-A1 Soft Chewable Pharmaceutical Products PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885
US-20190336442-A1 Manufacturing of Semi-Plastic Pharmaceutical Dosage Units PUF60, RPS11, RPS20 ELANE 4476/4885FAAH 4017/4885AURKA 4249/4885
US-20120094981-A1 ANTHELMINTIC AGENTS AND THEIR USE ABCB11, ACHE, CMA1 ELANE 137/4885FAAH 51/4885AURKA 920/4885
US-20170172986-A1 SOFT CHEWABLE PHARMACEUTICAL PRODUCTS PAM, TAS2R46, TAS2R16 ELANE 3486/4885FAAH 1769/4885AURKA 2932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.